Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An instance of adrenal cortex carcinoma that is caused by an inherited modification of the individual's genome.
Features include always present findings: Choroid plexus carcinoma and Adrenocortical carcinoma.
Age of onset: infancy.
Biomarker and diagnostic research for adrenocortical carcinoma, hereditary has been reported in the published literature.
Phenotype severity distribution: 2 always present features.
No clinical trials have been registered for adrenocortical carcinoma, hereditary.
88 publications have been identified in PubMed for adrenocortical carcinoma, hereditary. Research spans Case Report / Case Series (26%), Basic Science / Preclinical (20%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 23 | 26% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:47 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Laboratory research
17 |
20% |
Research summaries | 12 | 14% |
Disease patterns and progression | 12 | 14% |
Testing and diagnosis research | 11 | 13% |
Clinical study results | 9 | 10% |
New treatment approaches | 3 | 3% |
Triebig AS (2026). [PMID: 42151378](https://pubmed.ncbi.nlm.nih.gov/42151378/). *Sci Rep*. [Basic Science / Preclinical]
Araujo-Castro M (2026). [PMID: 41824768](https://pubmed.ncbi.nlm.nih.gov/41824768/). *The Journal of clinical endocrinology and metabolism*. [Clinical Trial Publication]
AlShoaibi M (2026). [PMID: 41552732](https://pubmed.ncbi.nlm.nih.gov/41552732/). *Cureus*. [Case Report / Case Series]
Srivatsa S (2026). [PMID: 41423574](https://pubmed.ncbi.nlm.nih.gov/41423574/). *Annals of surgical oncology*. [Case Report / Case Series]
Messaoud M (2026). [PMID: 41676208](https://pubmed.ncbi.nlm.nih.gov/41676208/). *AME case reports*. [Basic Science / Preclinical]
Wudy SA (2026). [PMID: 41225718](https://pubmed.ncbi.nlm.nih.gov/41225718/). *J Clin Endocrinol Metab*. [Diagnostic / Biomarker]
Mastrangelo S (2026). [PMID: 42201467](https://pubmed.ncbi.nlm.nih.gov/42201467/). *Discov Oncol*. [Case Report / Case Series]
Greenberg SE (2026). [PMID: 42067272](https://pubmed.ncbi.nlm.nih.gov/42067272/). *Endocrinol Metab Clin North Am*. [Review / Meta-Analysis]
Cavalcanti MM (2026). [PMID: 42189769](https://pubmed.ncbi.nlm.nih.gov/42189769/). *Arch Endocrinol Metab*. [Basic Science / Preclinical]
Cioppi F (2026). [PMID: 41806143](https://pubmed.ncbi.nlm.nih.gov/41806143/). *Endocrine pathology*. [Basic Science / Preclinical]
AI-curated news mentioning adrenocortical carcinoma, hereditary
Updated Sep 10, 2026
A recent study published in PubMed highlights the severity and management strategies for hypercortisolism in patients with adrenocortical carcinoma and overt Cushing's syndrome. The findings provide insights into treatment approaches for this rare condition.
A recent publication explores the patient experience of adrenocortical carcinoma through the perspectives of a patient, his physician, and a patient association. This study highlights the challenges faced by patients and the importance of patient-centered care in managing this rare cancer.
Recent research provides insights into the pathogenesis and treatment of adrenocortical carcinoma at a single-cell resolution. This study enhances understanding of the disease's biology, potentially guiding future therapeutic strategies.